JP2024513781A5 - - Google Patents
Info
- Publication number
- JP2024513781A5 JP2024513781A5 JP2023558897A JP2023558897A JP2024513781A5 JP 2024513781 A5 JP2024513781 A5 JP 2024513781A5 JP 2023558897 A JP2023558897 A JP 2023558897A JP 2023558897 A JP2023558897 A JP 2023558897A JP 2024513781 A5 JP2024513781 A5 JP 2024513781A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- clonal
- probability
- proportion
- sequence data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2104715.4A GB202104715D0 (en) | 2021-04-01 | 2021-04-01 | Identification of clonal neoantigens and uses thereof |
| GB2104715.4 | 2021-04-01 | ||
| PCT/EP2022/058793 WO2022207925A1 (en) | 2021-04-01 | 2022-04-01 | Identification of clonal neoantigens and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513781A JP2024513781A (ja) | 2024-03-27 |
| JP2024513781A5 true JP2024513781A5 (enExample) | 2025-04-28 |
Family
ID=75883641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558897A Pending JP2024513781A (ja) | 2021-04-01 | 2022-04-01 | クローナルなネオ抗原の同定及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11504398B2 (enExample) |
| EP (1) | EP4313125A1 (enExample) |
| JP (1) | JP2024513781A (enExample) |
| KR (1) | KR20230165259A (enExample) |
| CN (1) | CN117120080A (enExample) |
| AU (1) | AU2022251011A1 (enExample) |
| CA (1) | CA3213222A1 (enExample) |
| GB (1) | GB202104715D0 (enExample) |
| IL (1) | IL306136A (enExample) |
| WO (1) | WO2022207925A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202104715D0 (en) * | 2021-04-01 | 2021-05-19 | Achilles Therapeutics Uk Ltd | Identification of clonal neoantigens and uses thereof |
| GB202202880D0 (en) | 2022-03-02 | 2022-04-13 | Achilles Therapeutics Uk Ltd | Methods for peptide synthesis |
| GB202205147D0 (en) | 2022-04-07 | 2022-05-25 | Achilles Therapeutics Uk Ltd | Identification of clonal neoantigens and uses thereof |
| EP4681208A1 (en) | 2023-03-17 | 2026-01-21 | T-Cypher Bio Ltd | Prediction of immunogenicity |
| GB202307096D0 (en) | 2023-05-12 | 2023-06-28 | Achilles Therapeutics Uk Ltd | Method |
| WO2024256485A1 (en) | 2023-06-15 | 2024-12-19 | Achilles Therapeutics Uk Limited | Identification of neoantigen peptides |
| GB202407727D0 (en) | 2024-05-31 | 2024-07-17 | Ucl Business Ltd | Reporters constructs, systems and assays |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2882867A1 (en) | 2012-08-10 | 2015-06-17 | The Broad Institute, Inc. | Methods and apparatus for analyzing and quantifying dna alterations in cancer |
| BR112015025460B1 (pt) * | 2013-04-07 | 2024-01-02 | The Broad Institute, Inc. | Método para a produção de uma vacina personalizada contra a neoplasia para um indivíduo diagnosticado como tendo uma neoplasia, vacina personalizada e uso da mesma |
| US11725237B2 (en) * | 2013-12-05 | 2023-08-15 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
| JP6740127B2 (ja) | 2013-12-06 | 2020-08-12 | ザ・ブロード・インスティテュート・インコーポレイテッド | 新生物ワクチン用製剤 |
| NZ721908A (en) | 2013-12-20 | 2022-12-23 | Massachusetts Gen Hospital | Combination therapy with neoantigen vaccine |
| ES2836273T3 (es) * | 2015-04-27 | 2021-06-24 | Cancer Research Tech Ltd | Método para el tratamiento del cáncer |
| TWI750122B (zh) | 2015-06-09 | 2021-12-21 | 美商博德研究所有限公司 | 用於贅瘤疫苗之調配物及其製備方法 |
| GB201516047D0 (en) * | 2015-09-10 | 2015-10-28 | Cancer Rec Tech Ltd | Method |
| JP6904953B2 (ja) * | 2015-12-03 | 2021-07-21 | アレス トレーディング ソシエテ アノニム | 細胞クローン性を決定する方法 |
| CA3050109A1 (en) * | 2017-01-18 | 2018-07-26 | Ichan School Of Medicine At Mount Sinai | Neoantigens and uses thereof for treating cancer |
| WO2018170578A1 (en) * | 2017-03-20 | 2018-09-27 | Ontario Institute For Cancer Research (Oicr) | Cancer risk based on tumour clonality |
| EP3651791A1 (en) * | 2017-07-14 | 2020-05-20 | The Francis Crick Institute Limited | Analysis of hla alleles in tumours and the uses thereof |
| EP3622522A1 (en) * | 2017-12-01 | 2020-03-18 | Illumina, Inc. | Methods and systems for determining somatic mutation clonality |
| IL259392A (en) * | 2018-05-15 | 2018-08-01 | Yeda Res & Dev | Vaccination with cancer neoantigens |
| US11189361B2 (en) * | 2018-06-28 | 2021-11-30 | International Business Machines Corporation | Functional analysis of time-series phylogenetic tumor evolution tree |
| CN111785322A (zh) * | 2019-12-30 | 2020-10-16 | 杭州慕谷基因科技有限公司 | 一种结肠腺癌基因组变异与肿瘤进化关系的研究方法 |
| GB202104715D0 (en) | 2021-04-01 | 2021-05-19 | Achilles Therapeutics Uk Ltd | Identification of clonal neoantigens and uses thereof |
| GB202205147D0 (en) * | 2022-04-07 | 2022-05-25 | Achilles Therapeutics Uk Ltd | Identification of clonal neoantigens and uses thereof |
-
2021
- 2021-04-01 GB GBGB2104715.4A patent/GB202104715D0/en not_active Ceased
-
2022
- 2022-04-01 WO PCT/EP2022/058793 patent/WO2022207925A1/en not_active Ceased
- 2022-04-01 CA CA3213222A patent/CA3213222A1/en active Pending
- 2022-04-01 US US17/711,372 patent/US11504398B2/en active Active
- 2022-04-01 EP EP22720410.4A patent/EP4313125A1/en active Pending
- 2022-04-01 CN CN202280026453.4A patent/CN117120080A/zh active Pending
- 2022-04-01 IL IL306136A patent/IL306136A/en unknown
- 2022-04-01 KR KR1020237035334A patent/KR20230165259A/ko active Pending
- 2022-04-01 JP JP2023558897A patent/JP2024513781A/ja active Pending
- 2022-04-01 AU AU2022251011A patent/AU2022251011A1/en active Pending
- 2022-10-11 US US17/963,665 patent/US12548651B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Roberts et al. | Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival | |
| JP7155470B2 (ja) | 免疫原性がん特異的エピトープのためのランク付けシステム | |
| CN113228190B (zh) | 分类和/或鉴定癌症亚型的系统和方法 | |
| Jonsson et al. | Mutations in collagen, type XVII, alpha 1 (COL17A1) cause epithelial recurrent erosion dystrophy (ERED) | |
| JP2019145114A (ja) | 高解像度での対立遺伝子の同定 | |
| JP2015533473A (ja) | 個別のがんワクチン及び適応免疫細胞療法 | |
| US10711311B2 (en) | Genomic rearrangements associated with prostate cancer and methods of using the same | |
| KR20190038935A (ko) | 면역요법 마커들 및 그 용도들(immunotherapy markers and uses therefor) | |
| Sammut et al. | Predictability of B cell clonal persistence and immunosurveillance in breast cancer | |
| Young et al. | Innate immune gene expression in Acropora palmata is consistent despite variance in yearly disease events | |
| JP2024513781A (ja) | クローナルなネオ抗原の同定及びその使用 | |
| Pinto et al. | Functional annotation of proteome encoded by human chromosome 22 | |
| CA3236814A1 (en) | Systems and methods for gene expression and tissue of origin inference from cell-free dna | |
| WO2021231614A1 (en) | System and method for gene expression and tissue of origin inference from cell-free dna | |
| Hasan et al. | Copy number architectures define treatment-mediated selection of lethal prostate cancer clones | |
| US20170072071A1 (en) | Inflammation-enabling polypeptides and uses thereof | |
| JP2017514505A (ja) | 急性骨髄性白血病の新規バイオマーカー | |
| Yamahira et al. | Ghost introgression in ricefishes of the genus Adrianichthys in an ancient Wallacean lake | |
| CN115925869B (zh) | Axin2突变体及其应用 | |
| CN112424382A (zh) | Hla多样性的定量评分 | |
| Ernst | Computational methods for improved cancer risk prediction based on multi-gene panel analysis in a routine diagnostic setting | |
| CN116083485B (zh) | 一种靶向载体、ATTRm疾病模型的构建方法及其应用 | |
| Skelly et al. | Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans | |
| Manyisa | Whole exome sequencing to investigate genetic variants of non-syndromic hearing impairment in a population of African ancestry | |
| JP2024533501A (ja) | 患者の腫瘍の個別化された新生抗原を生成する方法 |